Level D· Scientific groundwork from lab and animal studiesLaboratory StudyPubMedOpen access

Dipeptidyl peptidase-4 cell surface expression marks an abundant adipose stem/progenitor cell population with high stemness in human white adipose tissue.

Hatzmann FM., Großmann S., Waldegger P., Wiegers GJ., Mandl M., Rauchenwald T.

Laboratory Study on Face & Skin, published in Adipocyte (2022) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Laboratory Study
Journal
Adipocyte (2022)
Country
United States
Reported sample size
—
Source database
PubMed
PMID
36168895
PMCID
PMC9542856
DOI
10.1080/21623945.2022.2129060
Citations
14

Abstract (original English)

The capacity of adipose stem/progenitor cells (ASCs) to undergo self-renewal and differentiation is crucial for adipose tissue homoeostasis, regeneration and expansion. However, the heterogeneous ASC populations of the adipose lineage constituting adipose tissue are not precisely known. In the present study, we demonstrate that cell surface expression of dipeptidyl peptidase-4 (DPP4)/cluster of differentiation 26 (CD26) subdivides the DLK1 - /CD34 + /CD45 - /CD31 - ASC pool of human white adipose tissues (WATs) into two large populations. Ex vivo , DPP4 + ASCs possess higher self-renewal and proliferation capacity and lesser adipocyte differentiation potential than DDP4 - ASCs. The knock-down of DPP4 in ASC leads to significantly reduced proliferation and self-renewal capacity, while adipogenic differentiation is increased. Ectopic overexpression of DPP4 strongly inhibits adipogenesis. Moreover, in whole mount stainings of human subcutaneous (s)WAT, we detect DPP4 in CD34 + ASC located in the vascular stroma surrounding small blood vessels and in mature adipocytes. We conclude that DPP4 is a functional marker for an abundant ASC population in human WAT with high proliferation and self-renewal potential and low adipogenic differentiation capacity.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
AdipocytesAdipogenesisAdipose TissueAdipose Tissue, WhiteAntigens, CD34Cell DifferentiationDipeptidyl Peptidase 4HumansStem Cells

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research